Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

7TM Pharma reports encouraging phase I data on TM-38837

Nov. 16, 2010

Santarus launches Cycloset in U.S. to improve glycemic control in type 2 diabetes

Nov. 15, 2010

Merck Serono's Saizen recommended for approval in Europe

Nov. 15, 2010

Banyu Pharma claims new bile acid GPBA receptor agonists

Nov. 12, 2010

Hygeia Therapeutics completes preclinical studies of HYG-102

Nov. 12, 2010

FDA approves Egrifta for lipodystrophy in HIV-infected patients

Nov. 12, 2010

Repros Therapeutics reports on type B meeting with FDA regarding Androxal

Nov. 12, 2010

Bionovo receives FDA approval for clinical development plan for Menerba

Nov. 12, 2010

Patient screening complete for phase III rhGAD65 trial in type 1 diabetes

Nov. 10, 2010

ECLIPSE trial compares Epanova with Lovaza

Nov. 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...